SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-098532
Filing Date
2011-11-14
Accepted
2011-11-14 16:31:51
Documents
8
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c24480e10vq.htm 10-Q 277635
2 EXHIBIT 31.1 c24480exv31w1.htm EX-31.1 9119
3 EXHIBIT 32.1 c24480exv32w1.htm EX-32.1 3813
  Complete submission text file 0000950123-11-098532.txt   940932

Data Files

Seq Description Document Type Size
4 EX-101 INSTANCE DOCUMENT rgn-20110930.xml EX-101.INS 61500
5 EX-101 SCHEMA DOCUMENT rgn-20110930.xsd EX-101.SCH 8371
6 EX-101 CALCULATION LINKBASE DOCUMENT rgn-20110930_cal.xml EX-101.CAL 19241
7 EX-101 LABELS LINKBASE DOCUMENT rgn-20110930_lab.xml EX-101.LAB 76627
8 EX-101 PRESENTATION LINKBASE DOCUMENT rgn-20110930_pre.xml EX-101.PRE 48226
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15070 | Film No.: 111203177
SIC: 2834 Pharmaceutical Preparations